Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04086966 · ClinicalTrials.gov registry record · Phase 1
PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study
A Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04086966 is a Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants.
The verdict
NCT04086966, a Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This pilot study will investigate the use of PSMA-PET/MRI (Positron Emission Tomography/ Magnetic Resonance Imaging)to guide radiation treatment planning in patients with known or suspected locally metastatic prostate cancer at the time of diagnosis. Patients will undergo a single PSMA-PET/MRI (or PET/CT (Computed Tomography) in some circumstances) prior to initiation of treatment. Following development of a PSMA-PET guided radiation treatment plan, therapeutic radiation will be delivered per standard-of-care parameters and assessments of feasibility and tolerability will be performed.
Interventions
- DRUG [68Ga]PSMA-PET/MRI or PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2022-02-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04086966
The ClinicalTrials.gov registry entry for NCT04086966 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [68Ga]PSMA-PET/MRI or PET/CT is the first listed.
NCT04086966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04086966 about?
NCT04086966 is a clinical study titled "PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study". This pilot study will investigate the use of PSMA-PET/MRI (Positron Emission Tomography/ Magnetic Resonance Imaging)to guide radiation treatment planning in patients with known or suspected locally metastatic prostate cancer at the time of diagnosis. Patients will undergo a single PSMA-PET/MRI (or P...
What is the current status of trial NCT04086966?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-08-20. Estimated completion is 2022-02-23.
What interventions are being tested in trial NCT04086966?
The interventions under investigation include: [68Ga]PSMA-PET/MRI or PET/CT (DRUG).
Who is sponsoring clinical trial NCT04086966?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.